NHC Reports Third Quarter 2022 Earnings
National HealthCare Corporation (NHC) reported net operating revenues of $270.8 million for Q3 2022, down 2.1% from $276.7 million in Q3 2021. This drop was primarily due to a $10.4 million decrease in government stimulus income and the exit from seven skilled nursing facilities. However, same-facility net operating revenues rose by 3.8%. NHC's net loss attributable to the company was $2.4 million for Q3 2022, an improvement from $3.3 million a year ago. Adjusted net income fell to $7.8 million, down from $14.9 million.
- Same-facility net operating revenues increased by 3.8%.
- Improved net loss situation, down from $3.3 million to $2.4 million.
- Net operating revenues decreased by 2.1% compared to Q3 2021.
- Reduced government stimulus income by $10.4 million.
- Adjusted net income decreased from $14.9 million to $7.8 million.
- Inflationary wage pressures impacting labor costs.
For the quarter ended
(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.
About
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Forward-Looking Statements
Statements in this press release that are not historical facts are forward-looking statements.
Consolidated Statements of Operations | |||||||||||||||
(in thousands, except share and per share amounts) | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
(unaudited) | (unaudited) | ||||||||||||||
Revenues and grant income: | |||||||||||||||
Net patient revenues | $ |
260,247 |
|
$ |
254,817 |
|
$ |
776,661 |
|
$ |
708,648 |
|
|||
Other revenues |
|
10,596 |
|
|
11,491 |
|
|
33,584 |
|
|
33,916 |
|
|||
Government stimulus income |
|
- |
|
|
10,429 |
|
|
10,940 |
|
|
48,304 |
|
|||
Net operating revenues and grant income |
|
270,843 |
|
|
276,737 |
|
|
821,185 |
|
|
790,868 |
|
|||
Costs and expenses: | |||||||||||||||
Salaries, wages and benefits |
|
173,198 |
|
|
170,235 |
|
|
518,828 |
|
|
483,263 |
|
|||
Other operating |
|
72,883 |
|
|
73,109 |
|
|
218,279 |
|
|
204,211 |
|
|||
Facility rent |
|
10,294 |
|
|
10,204 |
|
|
30,770 |
|
|
30,437 |
|
|||
Depreciation and amortization |
|
10,253 |
|
|
10,229 |
|
|
30,011 |
|
|
30,521 |
|
|||
Interest |
|
137 |
|
|
198 |
|
|
451 |
|
|
657 |
|
|||
Total costs and expenses |
|
266,765 |
|
|
263,975 |
|
|
798,339 |
|
|
749,089 |
|
|||
Income from operations |
|
4,078 |
|
|
12,762 |
|
|
22,846 |
|
|
41,779 |
|
|||
Non-operating income |
|
2,731 |
|
|
3,399 |
|
|
8,451 |
|
|
15,245 |
|
|||
Gain on acquisition of equity method investment |
|
- |
|
|
- |
|
|
- |
|
|
95,202 |
|
|||
Unrealized losses on marketable equity securities |
|
(11,056 |
) |
|
(23,797 |
) |
|
(11,479 |
) |
|
(23,227 |
) |
|||
Income/(loss) before income taxes |
|
(4,247 |
) |
|
(7,636 |
) |
|
19,818 |
|
|
128,999 |
|
|||
Income tax (provision)/benefit |
|
1,140 |
|
|
4,090 |
|
|
(5,415 |
) |
|
(5,907 |
) |
|||
Net income/(loss) |
|
(3,107 |
) |
|
(3,546 |
) |
|
14,403 |
|
|
123,092 |
|
|||
Net (income)/loss attributable to noncontrolling interest |
|
678 |
|
|
198 |
|
|
1,689 |
|
|
(290 |
) |
|||
Net income/(loss) attributable to |
$ |
(2,429 |
) |
$ |
(3,348 |
) |
$ |
16,092 |
|
$ |
122,802 |
|
|||
Net income/(loss) per common share | |||||||||||||||
Basic | $ |
(0.16 |
) |
$ |
(0.22 |
) |
$ |
1.04 |
|
$ |
8.00 |
|
|||
Diluted | $ |
(0.16 |
) |
$ |
(0.22 |
) |
$ |
1.04 |
|
$ |
7.97 |
|
|||
Weighted average common shares outstanding | |||||||||||||||
Basic |
|
15,445,569 |
|
|
15,364,043 |
|
|
15,438,375 |
|
|
15,347,042 |
|
|||
Diluted |
|
15,445,569 |
|
|
15,364,043 |
|
|
14,577,103 |
|
|
15,414,683 |
|
|||
Dividends declared per common share | $ |
0.57 |
|
$ |
0.52 |
|
$ |
1.69 |
|
$ |
1.56 |
|
|||
Balance Sheet Data | |||||||||||||||
(in thousands) | 2022 |
2021 |
|||||||||||||
(unaudited) | |||||||||||||||
Cash, cash equivalents and marketable securities | $ |
176,729 |
|
$ |
256,025 |
|
|||||||||
Restricted cash, cash equivalents and marketable securities |
|
171,898 |
|
|
175,884 |
|
|||||||||
Current assets |
|
344,529 |
|
|
426,638 |
|
|||||||||
Property and equipment, net |
|
511,373 |
|
|
520,996 |
|
|||||||||
Total assets |
|
1,295,559 |
|
|
1,403,396 |
|
|||||||||
Current liabilities |
|
210,156 |
|
|
263,201 |
|
|||||||||
|
877,311 |
|
|
903,004 |
|
||||||||||
Selected Operating Statistics | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
(unaudited) | (unaudited) | ||||||||||||||
Skilled Nursing Per Diems: | |||||||||||||||
Medicare | $ |
535.60 |
|
$ |
523.98 |
|
$ |
540.30 |
|
$ |
528.60 |
|
|||
Managed Care |
|
429.22 |
|
|
404.43 |
|
|
425.39 |
|
|
406.32 |
|
|||
Medicaid |
|
237.61 |
|
|
231.39 |
|
|
230.79 |
|
|
225.68 |
|
|||
Private Pay and Other |
|
265.68 |
|
|
257.13 |
|
|
268.13 |
|
|
254.03 |
|
|||
Average Skilled Nursing Per Diem | $ |
302.43 |
|
$ |
295.40 |
|
$ |
301.91 |
|
$ |
297.04 |
|
|||
Skilled |
|||||||||||||||
Medicare |
|
81,940 |
|
|
87,534 |
|
|
258,961 |
|
|
271,024 |
|
|||
Managed Care |
|
52,956 |
|
|
57,486 |
|
|
163,823 |
|
|
183,593 |
|
|||
Medicaid |
|
302,500 |
|
|
315,979 |
|
|
919,931 |
|
|
895,955 |
|
|||
Private Pay and Other |
|
169,068 |
|
|
158,011 |
|
|
489,477 |
|
|
439,225 |
|
|||
Total Skilled |
|
606,464 |
|
|
619,010 |
|
|
1,832,192 |
|
|
1,789,797 |
|
|||
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
(unaudited) | (unaudited) | ||||||||||||||
Net income/(loss) attributable to |
$ |
(2,429 |
) |
$ |
(3,348 |
) |
$ |
16,092 |
|
$ |
122,802 |
|
|||
Non-GAAP adjustments | |||||||||||||||
Unrealized losses on marketable equity securities |
|
11,056 |
|
|
23,797 |
|
|
11,479 |
|
|
23,227 |
|
|||
Operating results for newly opened facilities not at full capacity (1) |
|
2,105 |
|
|
115 |
|
|
4,033 |
|
|
480 |
|
|||
Gain on acquisition of equity method investment |
|
- |
|
|
- |
|
|
- |
|
|
(95,202 |
) |
|||
Stock-based compensation expense |
|
639 |
|
|
726 |
|
|
1,980 |
|
|
1,905 |
|
|||
Income tax benefit on non-GAAP adjustments |
|
(3,588 |
) |
|
(6,406 |
) |
|
(4,548 |
) |
|
(6,369 |
) |
|||
Non-GAAP Net income | $ |
7,783 |
|
$ |
14,884 |
|
$ |
29,036 |
|
$ |
46,843 |
|
|||
GAAP diluted earnings/(loss) per share | $ |
(0.16 |
) |
$ |
(0.22 |
) |
$ |
1.04 |
|
$ |
7.97 |
|
|||
Non-GAAP adjustments | |||||||||||||||
Unrealized losses on marketable equity securities |
|
0.53 |
|
|
1.14 |
|
|
0.56 |
|
|
1.12 |
|
|||
Operating results for newly opened facilities not at full capacity (1) |
|
0.10 |
|
|
0.01 |
|
|
0.19 |
|
|
0.02 |
|
|||
Gain on acquisition of equity method investment |
|
- |
|
|
- |
|
|
- |
|
|
(6.16 |
) |
|||
Stock-based compensation expense |
|
0.03 |
|
|
0.03 |
|
|
0.09 |
|
|
0.09 |
|
|||
Non-GAAP diluted earnings per share | $ |
0.50 |
|
$ |
0.96 |
|
$ |
1.88 |
|
$ |
3.04 |
|
|||
(1) The newly opened facilities not at full capacity for the 2022 period presented consisted of operations opened from 2020 through 2022. This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency. The newly opened facilities for the 2021 period presented consisted of operations opened from 2019 through 2021. The 2021 period consisted of one memory care facility. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221103006385/en/
Phone: (615) 890-2020
Source:
FAQ
What were NHC's revenues for the third quarter of 2022?
What is the net loss reported by NHC for Q3 2022?
How did same-facility revenues perform in Q3 2022 for NHC?
What factors contributed to NHC's reduced income in Q3 2022?